GRISELDA BARTHA: Open Payments
NPI 1669567517 · FAR ROCKAWAY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 18 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $186 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $243 |
| Alkermes, Inc. | 4 | $160 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: INGREZZA, LYBALVI, ARISTADA, FANAPT, COBENFY, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
